Puma Biotechnology Competitors and Similar CompaniesClear all
Puma Biotechnology's competitors and similar companies include ImmunoGen.
 Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | |
Founding Date | Founding Date 2010 | Founding Date 1981 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Los Angeles, US HQ | Locations Waltham, US HQ |
Employees | Employees 27214% decrease | Employees 277161% increase |
Valuation ($) | Valuation ($) 136.8 m | Valuation ($) 8.7 b |
Financial | ||
Revenue (est.) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) $108.8m (FY, 2022) |
Cost of goods | Cost of goods $58.2m (FY, 2025) | Cost of goods $176k (FY, 2022) |
Gross profit | Gross profit $170.2m (FY, 2025) | Gross profit $108.6m (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 172m | Total funding raised $ 56m |
For sources of this data, please see the company profile
View Company Profiles
ImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View company